Analyst Rating: Will Arena Pharmaceuticals, Inc. (ARNA) Stock Do Better Than the Market?

Friday, October 22, 2021 03:15 PM | InvestorsObserver Analysts

Mentioned in this article

Analyst Rating: Will Arena Pharmaceuticals, Inc. (ARNA) Stock Do Better Than the Market?

Analysts who follow Arena Pharmaceuticals, Inc. (ARNA) on average expect it to climb 61.38% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. That average rating earns Arena Pharmaceuticals, Inc. an Analyst Ranking of 75, which means it ranks higher than 75 of stocks, based on data compiled by InvestorsObserver.

Wall Street analysts are rating ARNA a Strong Buy today. Find out what this means to you and get the rest of the rankings on ARNA!

See Full ARNA Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Arena Pharmaceuticals, Inc. Stock Today?

Arena Pharmaceuticals, Inc. (ARNA) stock is trading at $60.37 as of 3:13 PM on Friday, Oct 22, a decline of -$1.31, or -2.12% from the previous closing price of $61.68. The stock has traded between $60.27 and $61.49 so far today. Volume today is below average. So far 187,959 shares have traded compared to average volume of 421,199 shares. Click Here to get the full Stock Report for Arena Pharmaceuticals, Inc. stock.